The mortality due to cardiogenic shock complicating acute myocardialinfarction (AMI) is high even in patients with early revascularization.Infusion of low dose recombinant human brain natriuretic peptide (rhBNP) atthe time of AMI is well tolerated and could improve cardiac function. This evidence concerns the gene NPPB and Shock.